Details for Patent: RE47351

✉ Email this page to a colleague

Summary for Patent: RE47351

Scope and claims summary:

Title:	2-(N-pyrazolo)adenosines with application as adenosine A.sub.2A receptor agonists
Abstract:	N-pyrazole substituted 2-adenosine compounds and methods for using the compounds as A.sub.2A-adenosine receptor agonists useful to stimulate mammalian coronary vasodilation for therapeutic purposes and as adjuncts in cardiological imaging.
Inventor(s):	Zablocki; Jeff A. (Mountain View, CA), Elzein; Elfatih O. (Fremont, CA), Palle; Venkata P. (Sunnyvale, CA), Belardinelli; Luiz (Palo Alto, CA)
Assignee:	Gilead Sciences, Inc. (Foster City, CA)
Application Number:	15/635,017
Patent Claim Types: see list of patent claims	Use; Composition; Formulation; Compound;

Drugs Protected by US Patent RE47351

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: RE47351

PCT Information
PCT Filed	June 21, 2000	PCT Application Number:	PCT/US00/40281
PCT Publication Date:	December 28, 2000	PCT Publication Number:	WO00/78779

International Family Members for US Patent RE47351

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	1189916	⤷ Subscribe	C300477	Netherlands	⤷ Subscribe
European Patent Office	1189916	⤷ Subscribe	CA 2011 00005	Denmark	⤷ Subscribe
European Patent Office	1189916	⤷ Subscribe	91785	Luxembourg	⤷ Subscribe
European Patent Office	1189916	⤷ Subscribe	SPC004/2011	Ireland	⤷ Subscribe
European Patent Office	1189916	⤷ Subscribe	1190003-2.L	Sweden	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.